Joseph P. Kennedy III sold Adient PLC (NYSE: ADNT)
Joseph P. Kennedy III (D-MA), a U.S. Representative, has disclosed 1 trade in Adient PLC (ADNT) since 2017, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Joseph P. Kennedy III sold $15,001 - $50,000 of Adient PLC (NYSE: ADNT) on January 3, 2017. Since that trade, ADNT is down -60.81% against the S&P 500 up +275.11%, an outperformance of -335.92%.
Data updated
Joseph P. Kennedy III's ADNT trades vs the price
ADNT is down -60.81% since Joseph P. Kennedy III sold on January 3, 2017, versus +275.11% for the S&P 500.
Performance since this trade
All Joseph P. Kennedy III ADNT trades
Joseph P. Kennedy III & ADNT trading FAQ
Is it legal for Joseph P. Kennedy III to trade Adient PLC (ADNT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Adient PLC (ADNT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Joseph P. Kennedy III sell ADNT?
Joseph P. Kennedy III disclosed a sale of $15,001 - $50,000 of Adient PLC (ADNT) on January 3, 2017, according to public STOCK Act filings.
How has ADNT performed since Joseph P. Kennedy III's trade?
Since Joseph P. Kennedy III sold ADNT on January 3, 2017, the stock is down -60.81%, versus +275.11% for the S&P 500 over the same period, an outperformance of -335.92%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ADNT trades?
Quantellect tracks every disclosed congressional trade in Adient PLC (ADNT) on the Adient PLC congressional trading page, which aggregates filings across all members of Congress.
Joseph P. Kennedy III's ADNT tradesAll congressional filings for Adient PLCJoseph P. Kennedy III's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.